Profil
David Fuller is Chairman at EpiAxis Therapeutics Pty Ltd. since 2020.
Dr. Fuller is Chief Medical Officer at Dimerix Ltd. since 2023.
Former roles include Non-Executive Director at Linear Clinical Research Ltd., Non-Executive Director at AdAlta Ltd. from 2020 to 2026, and Chief Medical Officer at Racura Oncology Ltd. from 2021 to 2022.
Education includes an undergraduate degree from The University of Sydney.
Postes actifs de David Fuller
| Sociétés | Poste | Début |
|---|---|---|
| DIMERIX LIMITED | Directeur Technique/Scientifique/R&D | 01/10/2023 |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Président | 01/07/2020 |
Anciens postes connus de David Fuller
| Sociétés | Poste | Fin |
|---|---|---|
| ADALTA LIMITED | Directeur/Membre du Conseil | 17/04/2026 |
| RACURA ONCOLOGY LTD | Directeur Technique/Scientifique/R&D | 11/11/2022 |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Directeur/Membre du Conseil | - |
Linear Clinical Research Ltd. | Directeur/Membre du Conseil | - |
Formation de David Fuller
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimerix Ltd.
Dimerix Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of biopharmaceutical drugs | Health Technology |
AdAlta Ltd.
AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
Linear Clinical Research Ltd. | |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Health Technology |
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Health Technology |
















